Canary Speech

Canary Speech, Inc. is a healthcare technology company focused on turning conversational speech into objective health signals through AI-powered vocal biomarker analysis. Its patented platform analyzes acoustic and linguistic features, along with ambient listening, to surface behavioral, cognitive, safety, and wellness indicators that support earlier screening and clinical decision-making.

Canary Speech, Inc. positions voice as a vital sign and delivers non-invasive screening across clinical, virtual, and mobile workflows. The company serves organizations seeking to move beyond subjective questionnaires and episodic observation toward faster, scalable assessment, longitudinal monitoring, and more proactive care across healthcare delivery, remote engagement, and at-home wellness use cases.

Offerings, Capabilities, and Integrations

Canary Speech, Inc. offers an API-first voice biomarker platform built for real-time analysis of conversational speech. Its capabilities span ambient listening, vocal feature extraction, scoring, longitudinal tracking, reporting, and workflow-ready decision support for behavioral, cognitive, safety, and wellness use cases.

The platform is designed to fit into existing environments rather than require new hardware. Canary Speech, Inc. supports deployment across clinical and virtual care workflows, contact center operations, in-room monitoring environments, mobile intake experiences, and partner platforms, with secure cloud delivery and developer-oriented integration options for embedding voice analysis into third-party applications.

Products and Services

  • Canary Ambient™: Ambient listening and real-time voice analysis software that analyzes patient-clinician and other live conversations to identify cognitive and behavioral health signals and support care decisions.
  • Wellness API: API-first speech analysis platform that extracts vocal features, returns assessments in real time, and enables organizations to embed Canary Speech, Inc. voice biomarker capabilities into their own workflows and applications.
  • Canary Behavioral™: Clinical decision support offering for behavioral health screening that uses voice biomarkers to assess conditions and states such as anxiety, depression, stress, and mood changes.
  • Canary Cognitive™: Clinical decision support offering for cognitive and neurodegenerative screening, including use cases related to mild cognitive impairment and conditions such as Alzheimer’s, Parkinson’s, and Huntington’s disease.
  • Canary Safety™: Voice-driven safety monitoring offering for healthcare environments that detects aggression and violence risk indicators in real time and supports earlier staff response.
  • Canary Wellness: Employee wellness and burnout screening offering that uses voice biomarkers to support proactive workforce well-being and ongoing wellness check-ins.
  • Canary Signal: Named offering within the Canary Speech, Inc. vocal biomarker portfolio.
  • Canary Signal+: Named offering within the Canary Speech, Inc. vocal biomarker portfolio.
  • Canary Ambient™ Continuous Monitoring: Continuous ambient voice analysis capability for hospitals and clinical care environments that extends Canary Ambient™ with ongoing aggression detection and safety-focused monitoring.
  • iOS & Android Apps: Mobile applications for wellness screening, intake, data collection, and reporting, with support for white-label deployment and recurring user check-ins.

Target Customers

Canary Speech, Inc. primarily targets healthcare providers, hospitals, health systems, and care teams that need more objective ways to screen for behavioral and cognitive risk during routine interactions. It also addresses payer organizations, virtual care programs, remote patient monitoring models, and clinical call centers that want earlier insight without adding invasive workflows.

Beyond provider organizations, Canary Speech, Inc. targets clinical research teams and trial sponsors that need scalable participant monitoring, as well as employers and contact center operators focused on stress, burnout, and workforce wellness. Its partnership-led model also aligns with digital health platforms and caregiving solutions serving aging populations, at-home care, and broader access-to-care initiatives.

Cloud Integrations and Marketplace

  • Microsoft Azure Marketplace: Canary Speech, Inc. has a verified Microsoft Azure Marketplace presence for Canary Speech Ambient, extending the company’s distribution within Microsoft’s healthcare and AI ecosystem.
  • Microsoft Cloud for Healthcare: Canary Speech, Inc. has positioned its platform for use with Microsoft Cloud for Healthcare, including partner-led deployments for virtual care, remote patient monitoring, and broader healthcare workflow integration.
  • Microsoft Teams: Canary Speech, Inc. has described integration of its API platform into Microsoft Teams to bring voice biomarker workflows into virtual care and collaboration environments.

Key People

  • Henry O’Connell: Co-Founder & CEO
  • Jeff Adams: Co-Founder & Chief Speech Officer
  • Nate Blaylock: Chief Technology Officer
  • Jeremy McFadden: CFO & Chief Data Officer
  • Kang Hsu: Chief Medical Officer
  • Jill Tripp: Executive VP, Growth
  • David Brown: VP, Engineering
  • Doug Crockett: VP, Operations
  • Caitlyn Brooksby: VP, Marketing and Strategic Partnerships
  • Namhee Kwon: VP, Research

Key Facts

  • Headquarters: Provo, Utah, United States
  • Employees: Approximately 36 employees
  • Annual Revenue: Undisclosed
  • Parent Company: None
  • Subsidiaries: None
  • Publicly Listed: Not publicly listed
Canary Speech

Enter a search